baber/WOPTO huggingface dataset:
Patent EP-4107471-A1 (EP)
Title: Deterrent and electrical pulse-applying glove device
Inventor: TORROELLA SYLVAIN
IPC: F41H13/00
Filed: 2021-03-12
Abstract: The invention relates to a deterrent and electrical pulse-applying glove device (1), comprising a palm side (2) and a back-of-the-hand side (3) with an external face (4) and an internal face (5) respectively external and internal to the glove device (1), the outer face (4) of the palm side (3) having installed on it at least two application contacts (11, 121) designed to be connected, by way of electrical connection means (17) comprising at least one contactor (19), to an electric power source (13). More specifically, two application contacts (11, 12) are installed on the outer face (4) on the palm side (3) at a distance (D) from one another so as to generate an electric arc between said contacts (11, 12) when they are connected to the electric power source (13) through the contactor (19) designed to be actuated from the internal side (20) internal to the glove device (1).
Patent EP-4122299-A1 (EP)
Inventor: JOGDAND HARSHAWARDHAN
IPC: H05H1/28
Filed: 2021-03-16
Abstract: A liquid coolant tube for a plasma arc cutting torch including a hollow elongated inner body shaped to translate within a hollow elongated outer body. The hollow elongated outer body of the liquid coolant tube is shaped to fixedly connect to the plasma arc cutting torch and includes a set of electrode guides. An external surface of the hollow elongated outer body and the set of electrode guides partially define a set of coolant flow channels between the set of electrode guides. The set of electrode guides are shaped to facilitate alignment of an electrode within the plasma arc cutting torch.
Patent EP-4126052-A1 (EP)
Inventor: LABÃO ALPIARÇA SOUSA DE ALMEIDA CARLOS DIOGO
IPC: A61K47/64
Filed: 2021-03-29
Abstract: The present invention in various aspects and embodiments involves the use of CO releasing molecules, such as conjugates comprising tumour-selective ligands and groups capable of releasing carbon monoxide (CO), for exerting immunomodulatory effects in cancer treatment, such as reductions in the expression of immune checkpoint molecules and the level of inhibitory macrophages. This can reduce immunosuppression in tumour tissue and can be useful, for example, in the treatment of immunosuppressive cancers or the treatment of cancers in combination with cancer immunotherapy.
Patent EP-4139733-A1 (EP)
Inventor: SAVANAYANA OHM
IPC: G02B21/36
Filed: 2021-04-20
Abstract: Examples relate to a microscope system and to a corresponding system, method and computer program for a microscope system. The system comprises one or more processors and one or more storage devices. The system is configured to detect a presence of a finger of a user of the microscope at a control input device for controlling the microscope system. The system is configured to identify a control functionality associated with the control input device. The system is configured to generate a visual overlay based on the identified control functionality. The visual overlay comprises a representation of the control functionality. The system is configured to provide a display signal to a display device of the microscope system. The display signal comprises the visual overlay.
Patent EP-4143653-A1 (EP)
Inventor: BAIER FABIAN
IPC: G05D1/02
Filed: 2021-04-27
Abstract: L'invention concerne un procédé de navigation d'un robot (10) déplacé au moyen d'une unité d'entraînement, dans lequel un premier système de navigation associé à une première zone (12) détermine un premier trajet de déplacement dans la première région à l'aide de premières données environnementales de la première région (12) et fournit des premières données de commande correspondantes servant à déplacer le robot (10) le long du premier trajet de déplacement pour l'unité d'entraînement du robot (10). Un second système de navigation, qui est attribué à une seconde région (14) qui se déplace par rapport à la première région (12), détermine un second trajet de déplacement dans la seconde région à l'aide de secondes données environnementales de la seconde région (14) et fournit des secondes données de commande correspondantes à l'unité d'entraînement du robot (10) pour se déplacer le long du second trajet de déplacement.
Patent EP-4158892-A1 (EP)
Inventor: GALPIN Franck
IPC: H04N19/577
Filed: 2021-05-18
Abstract: For a bi-prediction block, the initial motion field can be refined using a DNN. In one implementation, the initial motion field is integer rounded to obtain initial prediction blocks. Based on the initial prediction, the DNN can generate motion refinement information, which is scaled and added to the sub-pel residual motion from the initial motion field to generate a refined motion field. The scaling factor can take a default value, or be based on the motion asymmetry. While the initial motion field is usually block based on sub-block based, the refined motion field is pixel based or sub-block based and can be at an arbitrary accuracy. The same refinement process is performed at both the encoder and decoder, and thus the motion refinement information need not to be signaled. Whether the refinement is enabled can be determined based on the initial motion, the block activities and the block size.
Patent EP-4154309-A1 (EP)
Inventor: VASSAL SIMON
IPC: H01L23/498
Filed: 2021-05-20
Abstract: The invention relates to an electric circuit, for example of the printed circuit type, for producing a module intended to be integrated into a chip card. This module comprises electric contact pads - or connectors (3) - allowing the chip to be connected to, and to communicate with, a read/write system. In order to give them a colour different from the gold and silver colours generally used, these electric contact pads (3) are at least partially covered with a surface layer (14) comprising a compound of the XpOqNrCs type, wherein X can be Hf, Ta, Zr, Nb, Mo, Cr, V, Ti or Sc, wherein p, q > 0 and r ≥ 0 and/or s ≥ 0. The invention also relates to a method for producing such an electric circuit.
Patent EP-4153579-A1 (EP)
Inventor: HERBLOT MARTIN
IPC: C07D311/82
Filed: 2021-05-14
Abstract: The invention relates to a novel xanthene derivative of formula (I) or formula (II), to mixtures comprising same, to a method for preparing said compound or said mixtures as well as to corresponding uses.
Patent EP-4181784-A1 (EP)
Title: Device for obtaining an indicator of a microcirculatory condition
Inventor: VAN WETERINGEN WILLEM
IPC: A61B5/1455
Filed: 2021-06-21
Abstract: The invention relates to a device (1) and a method for obtaining an indicator of the microcirculatory condition of a patient. The device (1) comprises at least one sensor (2) for measuring data indicative of an arterial blood oxygen level, at least one sensor (3) for measuring data indicative of a tissue oxygen level and a control unit (4) for determining a measure of microcirculation, in particular changes in tissue perfusion on the basis of the tissue oxygen level and the arterial blood oxygen level.
Patent EP-4138689-A1 (EP)
Inventor: EVANS GARY
IPC: A61B17/22
Filed: 2021-06-16
Abstract: A pressure wave device (10) for treating biological tissue, comprising - a handpiece (12), - a pneumatic drive element (14) accelerating a projectile (28) of the handpiece (12), and - a first compressor (21) and a second compressor (22) to supply gas to the pneu- matic drive element (14) for accelerating the projectile (28), wherein the pressure wave device (10) is configured to be switchable between -- a first operation mode, only the first compressor (21) supplying gas to the pneu- matic drive element (14), and -- a second operation mode, at least the second compressor (22) supplying gas to the pneumatic drive element (14).
Patent EP-4153243-A1 (EP)
Inventor: GONG SHAOQIN
IPC: C12N15/87
Filed: 2021-05-18
Abstract: The present technology provides a nanoparticle comprising: a silica network comprising crosslinked polysiloxanes, wherein the crosslinks between polysiloxanes comprise disulfide linkages, the polysiloxanes optionally bear weakly basic functional groups, the nanoparticle comprises an exterior surface comprising surface-modifying groups attached to and surrounding the silica network, wherein the surface-modifying groups comprising polyethylene glycol (PEG), polysarcosine, polyzwitterion or combinations of two or more of thereof; and the nanoparticle has an average diameter of 15 nm to 500 nm. The nanoparticles herein may include biomolecules such as polynucleic acids, proteins, and complexes thereof, e.g, Cas9 RNP.
Patent EP-4189346-A1 (EP)
Inventor: ALIOLI MATTIA
IPC: G01F1/00
Filed: 2021-06-21
Abstract: Selon le procédé de l'invention, la substance (FL) à mesurer peut s'écouler à travers une conduite dans un sens d'écoulement spécifié, et une valeur de température de paroi XTw qui représente une température de paroi Tw, à savoir la température d'une paroi entourant une lumière du tube, est évaluée. En outre, une valeur de densité Xp qui représente la densité p de la substance à mesurer s'écoulant dans la conduite, une valeur de viscosité Χμ qui représente la viscosité µ de la substance à mesurer s'écoulant dans la conduite, une valeur de conductivité de température Χλ qui représente la conductivité de température λ de la substance à mesurer, une valeur de capacité thermique Xcp qui représente la capacité thermique spécifique cp de la substance à mesurer et une valeur de différentiel de pression ΧΔρ qui représente un différentiel de pression Δρ produit à l'intérieur de la substance à mesurer s'écoulant dans la conduite dans le sens d'écoulement sont déterminées et ensuite utilisées pour déterminer une valeur de nombre caractéristique Xv d'un nombre caractéristique V de la substance à mesurer, ledit nombre caractéristique caractérisant une chauffe de la substance à mesurer s'écoulant dans la conduite en conséquence de la dissipation, le nombre caractéristique V de la substance à mesurer correspondant à une formule de calcul : V = ƒ(Δp,p,μ,λ,c p ) = Pr a  ∙ Ec b  · ζ c , qui est déterminée par un nombre d'Eckert Ec de la substance à mesurer s'écoulant dans la conduite, un nombre de Prandtl Pr de la substance à mesurer s'écoulant dans la conduite, et un coefficient de perte de pression ζ de la conduite ainsi que par un premier exposant spécifique à la conduite a, un deuxième exposant spécifique à la conduite b, et un troisième exposant spécifique à la conduite c. Enfin, une valeur de température XTM qui représente la température TM de la substance à mesurer est déterminée à l'aide de la valeur de nombre caractéristique Xv et de la valeur de température de paroi XTw. À cet effet, un système de mesure selon l'invention comprend en outre un capteur de température, qui est thermiquement couplé à une surface latérale de la paroi, destiné à générer un signal de mesure de température, qui réagit à une variation de la température Tw de la paroi par une modification d'au moins un paramètre de signal, et un système électronique de mesure et d'exploitation qui est électriquement connecté au capteur de température.
Patent EP-4090642-A1 (EP)
Title: Consortiums de micro-organismes pour une administration spatiale et temporelle d'azote
Inventor: TEMME KARSTEN
IPC: C05F11/08
Filed: 2021-01-12
Abstract: La présente invention concerne des consortiums de microbes qui sont fonctionnellement optimisés pour la fixation de l'azote et sa distribution à des plantes de manière ciblée, efficace et écologique. Les microbes appartenant au consortium diffèrent en termes d'utilisation des nutriments, d'occupation temporelle, d'adaptabilité à l'oxygène et/ou d'occupation spatiale, ce qui permet aux microbes de distribuer l'azote à une plante céréalière d'une manière ciblée dans l'espace (par exemple, rhizosphérique) et ciblée dans le temps (par exemple, pendant des étapes avantageuses du cycle de vie de la plante).<i />
<i /> La présente invention concerne également des procédés de création d'une composition synthétique de microbes et des procédés d'utilisation des compositions de microbes pour fixer l'azote atmosphérique et le distribuer à une culture.
Patent EP-4090935-A1 (EP)
Inventor: LARSON MICHAEL C
IPC: G01N1/30
Filed: 2021-01-12
Abstract: Optical biopsy staining panels for in vivo or in situ fluorescent staining of optical tissue (or other appropriate tissue), e.g., for the purpose of a direct biopsy such as an optical biopsy. The stain panels may feature a combination of a nuclear stain and a cytoplasmic stain, as a means of functioning as an in vivo or in situ hematoxylin and eosin (H&E) stain. Examples of said stains may include anthracyclines such as Daunorucibin, acriflavines like Proflavine, anthracenediones such as Mitoxantrone, phenothiazines like Methylene Blue, and tri- and tetra-heterocyclic dyes like Fluorescein, Phloxine B, Phenol Red, Rose Bengal, Congo Red, and Indigo Carmine.
Patent EP-4090271-A1 (EP)
Title: A medical device
Inventor: VAN NIEKERK HENRY WALTER
IPC: A61B17/34
Filed: 2021-01-14
Abstract: This invention relates to a medical device. The device includes an elongate cannula which is insertable into a blood vessel and which is resiliently biased towards a closed condition in which it inhibits fluid flow through the cannula. The cannula is displaceable away from its closed position by the introduction of a displacement arrangement such as a device or instrument or a pressurised fluid and reverts to its closed condition when the displacement arrangement is removed from the cannula to inhibit the flow of blood therethrough. The invention further relates to a needle for use with the medical device, to a kit and to a method of accessing a blood vessel. In addition, it relates to a method of closing an incision in a blood vessel and to a closure member for use in the method.
Patent EP-4182020-A1 (EP)
Inventor: REN ZAIFANG
IPC: A61P3/04
Filed: 2021-07-20
Abstract: The application relates to a compound of Formula (I) : or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of GLP-1 receptor, a pharmaceutical composition comprising a compound of Formula (I), and a method of treating or preventing a disease in which GLP-1 receptor plays a role.
Patent EP-4179852-A1 (EP)
Inventor: DUNBAR STEPHEN M
IPC: H05H1/38
Filed: 2021-07-08
Abstract: A jacketed consumable cartridge is provided for a liquid cooled plasma arc torch. The jacketed consumable cartridge comprises an electrode, a swirl ring securely affixed to and disposed circumferentially about a distal end of the electrode, and a nozzle securely affixed to the swirl ring, the nozzle disposed circumferentially about the distal end of the electrode with a portion of the swirl ring located therebetween. The cartridge also comprises a cartridge jacket securely affixed to and disposed circumferentially about a distal end of the nozzle and a shield securely affixed to and disposed circumferentially about a distal end of the cartridge jacket. A proximal end of the cartridge jacket is adapted to extend (i) axially past a proximal end of the shield and (ii) radially beyond a radial extent of the shield.
Patent EP-4200225-A1 (EP)
Title: Hinged zipper assembly of a resealable enclosure
Inventor: WIHLBORG LARS
IPC: B65D33/25
Filed: 2021-08-18
Abstract: A hinged zipper assembly includes first and second zipper members each having a facing side, an opposite side, an upper edge, and an opposite lower edge. Each of the zipper members has a profile protrusion that extends from the facing sides and are located between the upper and lower edges. The profile protrusions mesh with each other to interlock with each other. A living hinge is formed in the first zipper member and/or the second zipper member between the lower edge and the profile protrusion. The zipper members are formed with flanges that extend from the lower edges. The flanges are configured to be affixed to panels of an enclosure that is closed by meshing of the profile protrusions of the first and second zipper members with each other.
Patent EP-4192383-A1 (EP)
Inventor: OFER NIR
IPC: A61B34/10
Filed: 2021-07-26
Abstract: A surgical positioning system includes an emitter secured to a medical implant; at least three microphones; at least one processor; and a memory. The emitter has a speaker and a power source. The memory stores instructions for execution by the processor that, when executed, cause the processor to receive, from each of the at least three microphones, information about a detected sound; and calculate, based on position information corresponding to each of the at least three microphones and the received information, a position of the implant.
Patent EP-4129629-A1 (EP)
Inventor: KIKUCHI MASANAO
IPC: B29C33/38
Filed: 2021-03-17
Abstract: A method for fabricating an imprint master 1 comprises a first forming step of forming micro-protrusion-and-recess structures 23 having a first average pitch on one surface of a substrate 10 and a second forming step of forming main recesses 21 or main protrusions 22 having a second average pitch larger than the first average pitch on the one surface of the substrate 10 having the micro-protrusion-and-recess structures 23 formed thereon, in a manner maintaining a shape of at least a portion of the micro-protrusion-and-recess structures 23 in the main recesses 21 or the main protrusions 22 while the main recesses 21 or the main protrusions 22 are being formed.
Patent EP-4131564-A1 (EP)
Inventor: FUJII YUSUKE
IPC: H01M50/20
Filed: 2021-01-20
Abstract: Power source device (100) includes: battery stack (10) in which a plurality of battery cells (1) are stacked; a pair of end plates (20) that each have a plate shape having a main surface and a side surface intersecting the main surface, are formed with plate screw hole (28) on the side surface, and are arranged on both side end surfaces of battery stack (10); a plurality of fastening members that are extended in stack direction of the battery stack (10), have fastening screw holes (39d) opened at ends, and couple end plates (20) to each other; and bolt (29) that is inserted into fastening screw hole (39d) of each fastening member and plate screw hole (28) of end plate (20) to fix the fastening member to end plate (20). The fastening member includes plate-shaped fastening body (39a), intermediate part (39b) obtained by bending both ends of fastening body (39a), and coupling piece (39c) obtained by bending an end of intermediate part (39b) far from fastening body (39a) to provide a height difference from fastening body (39a) and form fastening screw hole (39d).
Patent EP-4089890-A1 (EP)
Inventor: OKITA SOU
IPC: F16H3/72
Filed: 2021-03-31
Abstract: A first rotation shaft (which is provided with a first gear (G1)) is assembled to a first case member (11) so as to provide a first assembly (AS1). A second rotation shaft (which is provided with a second gear (G2)) and a third rotation shaft (which is provided with a third gear (G3)) are assembled to a support member (13) so as to provide a second assembly (AS2). When the second assembly (AS2) is assembled to the first assembly (AS1), the second assembly (AS2) is rotatable around a third axis (AX3) from a first position where the first gear (G1) and the second gear (G2) are located away from each other to a second position (P2) where the first gear (G1) and the second gear (G2) are in mesh with each other, and is positioned at the second position (P2) by using a positioning member (60A, 60B).
Patent EP-4129149-A1 (EP)
Inventor: TARUMOTO TETSUYA
IPC: A61B1/018
Filed: 2021-02-16
Abstract: Provided are an elevator that can be reliably attached by a simple operation and an endoscope including the elevator. An elevator (6) engages with and attached to an engagement end (80) of a rotation shaft protruding from a distal end portion (22) of the endoscope by being pushed in from a direction intersecting with an axial length direction, and is elevated according to rotation of the rotation shaft. Ajig (9) is connected to the elevator (6), and the jig (9) has a grip portion (91) that is gripped when the elevator (6) is attached and can be separated after the attachment.
Patent EP-4203791-A1 (EP)
Inventor: PANKEN ERIC J
IPC: A61B5/327
Filed: 2021-08-26
Abstract: In some examples, a device includes at least three electrodes a first pair of electrodes and a second pair of electrodes. The device also includes circuitry configured to generate a first cardiac signal based on a first differential signal received across the first pair, generate a first brain signal based on the first differential signal received across the first pair, generate a second cardiac signal based on a second differential signal received across the second pair, and generate a second brain signal based on the second differential signal received across the second pair. The circuitry is also configured to output a composite cardiac signal based on the first cardiac signal and the second cardiac signal and to output a composite brain signal based on the first brain signal and the second brain signal.
Patent EP-4225359-A1 (EP)
Inventor: PAPASOTIRIOU IOANNIS
IPC: A61K39/12
Filed: 2021-10-12
Abstract: The present invention concerns a pharmaceutical product for use as a vaccine against a viral disease in a human or animal subject, comprising three compositions comprising activated, autologous dendritic cells, loaded with three different SARS-CoV-2 peptides, to be administered in three separate doses sequentially to the human or animal subject.
Patent EP-4136589-A1 (EP)
Inventor: MATSUURA SHUNJI
IPC: G06J1/00
Filed: 2021-04-16
Abstract: A method of solving a problem using a digital computer operatively coupled to a non-classical computer may include providing a qubit Hamiltonian in said memory, wherein said qubit Hamiltonian comprises two-qubit coupling interactions on at least two axes; using said one or more computer processors to generate a unitary transformation, wherein said unitary transformation comprises an expression of a first two-qubit coupling interaction on a first axis using a second two-qubit coupling interaction on a second axis, which first axis is orthogonal to said second axis; embedding said qubit Hamiltonian on said non-classical computer; implementing said unitary transformation on said non-classical computer to apply a two-qubit coupling interaction along said first axis; and providing an expected value of said qubit Hamiltonian at an interface of said computer processor, wherein said expected value comprises said solution to said problem.
Patent EP-4138856-A1 (EP)
Inventor: NEL ANDRE E
IPC: A61K31/711
Filed: 2021-04-19
Abstract: In various embodiments immunogenic nanoparticles are provided that are capable of raising an immune response directed against one or more viral proteins and/or protein fragments. In certain embodiments the immunogenic nanoparticles raise an immune response directed against a virus (e.g., SARS-CoV-2 (2019-nCoV), SARS-CoV-2, and MERS-CoV, and the like). In certain embodiments the immunogenic nanoparticles comprise a nanoparticle formed from one or more biocompatible polymer(s), one or more viral proteins or fragments thereof encapsulated within or attached to the biocompatible polymer(s) where the viral protein or fragment thereof comprises an antigen to which an immune response is to be induced by administration of the immunogenic nanoparticle to a mammal and where the immunogenic nanoparticle further comprises an adjuvant (e.g., a STING agonist).